Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LRRC2P1 (LRRC2 pseudogene 1) is a human pseudogene related to the leucine-rich repeat containing 2 (LRRC2) gene. Pseudogenes are DNA sequences that closely resemble known genes but do not produce functional proteins or RNAs in regular biological contexts. Unlike LRRC2, which is a protein-coding gene involved in tumor suppression and mitochondrial/cardiac biology, LRRC2P1 is not associated with any known biological activity, tissue expression, or disease process. There are no recognized aliases, functions, family classifications, clinical markers, or drug interactions for LRRC2P1. LRRC2P1 is best described as a human pseudogene without functional activity or clinical utility. If a target is sought for drug discovery or disease association, LRRC2 (not LRRC2P1) may be relevant. For structured databases, LRRC2P1 represents a non-functional pseudogene entry.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LRRC2 pseudogene 1 (LRRC2P1).